🔥 VIRAL
📢 SARTORIUS STEDIM BIOTECH : Obtiene una recomendación de compra de JP Morgan - MarketScreener España
🔥 VIRAL
📢 SARTORIUS STEDIM BIOTECH : Obtiene una recomendación de compra de JP Morgan - MarketScreener España
🦠Spore batteriche come micro-scudi: più stabilità per vaccini ed enzimi, nuove strade per biotecnologie accessibili e resistenti. #Scienza #Biotech
🔗 https://www.tomshw.it/scienze/queste-spore-batteriche-potrebbero-aiutare-vaccini-ed-enzimi

Children of long-lived parents develop cardiometabolic diseases 13 years later than average. Now, researchers have isolated the exact CGAS gene mutation responsible for this extended healthspan.

A Nobel Prize winner just walked out of Google's top AI lab. John Jumper, who shared the 2024 chemistry Nobel for AlphaFold, is leaving Google DeepMind for Anthropic, one day after another Google star left for OpenAI. What Anthropic wants with a protein scientist is the surprise.
In a massive technological upset, China’s National Medical Products Administration has officially granted the world’s first commercial approval for an invasive brain-computer interface beating Elon Musk’s Neuralink to the mass market.
#neurotech #braincomputerinterface #bci #neuralink #elonmuskquotes #technews #futuretech #biotech #neuroscience #chinatech
The Most Promising Ebola Vaccine Has Been Sitting on the Shelf for 15 Years
https://web.brid.gy/r/https://www.wired.com/story/ebola-vaccine-sitting-on-shelf-for-15-years/
The 3-Step Process of Platelet-Rich Plasma (PRP) 🧪🧬.
​ How exactly does a blood draw turn into a powerful joint repair treatment? We break down the clinical science behind PRP: from the initial draw and the high-speed centrifuge spin to the targeted injection that restarts your body’s healing timeline.
Https://regenstep.com/prp-platelet-rich-plasma-joint-repair/
#MedicalScience #HowItWorks #PRPInjection #CellularHealth #Biotech #HealthyLifestyle #Orthopedics #HealthEducation
A Londra parte entro fine anno il primo trial al mondo che prova a "ringiovanire" il sistema immunitario con un'iniezione. Le cellule T che ci difendono si stancano con l'età e smettono di funzionare: la molecola sviluppata dalla SenTcell dovrebbe rimetterle in moto.
Nei topi è andata bene, +70% di vita. Solo che chi ha inventato la molecola è anche il CEO della società . Per quanto abbia alle spalle recenti studi già convalidati, seguiamo con prudenza.
https://www.futuroprossimo.it/2026/06/uk-ringiovanimento-delle-cellule-immunitarie-al-via-la-fase-1/
A flexible graphene-based neural interface can 'speak and listen' to the brain